abstract |
The invention discloses a thiazole aminobenzamide acetate derivative with antitumor activity, which can be used for preparing anticancer drugs, especially as a Bcr-Abl tyrosine kinase inhibitor, especially as a T315I mutation Bcr‑Abl tyrosine kinase inhibitor. |